Plain-English translation of NCT07162506 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether patients with advanced esophageal squamous cell carcinoma who have responded well to initial treatment with and might do equally well—or even better—with radiation and (called camrelizumab maintenance therapy) instead of surgery to remove the esophagus. The goal is to see if avoiding surgery while keeping the esophagus is possible for some patients, alongside ongoing .
Surgery to remove the esophagus is a major operation with significant side effects and recovery time. Researchers want to know if some patients can be spared from surgery and still achieve excellent outcomes using radiation and combined with instead.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be assigned to one of two groups based on your preference: one group will receive surgery to remove the esophagus and surrounding lymph nodes, while the other will receive radiation therapy (28 treatments over several weeks) combined with (two cycles), followed by ongoing for up to one year. You will have regular follow-up visits and imaging scans to monitor your response and overall health throughout the study.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China